Geode Capital Management, LLC Atea Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,924,773 shares of AVIR stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,924,773
Previous 2,009,803 4.23%
Holding current value
$6.14 Million
Previous $6.65 Million 3.08%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$3.17 - $4.02 $269,545 - $341,820
-85,030 Reduced 4.23%
1,924,773 $6.45 Million
Q2 2024

Aug 09, 2024
BUY
$3.31 - $4.04 $421,439 - $514,384
127,323 Added 6.76%
2,009,803 $6.65 Million
Q1 2024

May 13, 2024
BUY
$3.09 - $4.56 $230,415 - $340,030
74,568 Added 4.12%
1,882,480 $7.61 Million
Q4 2023

Feb 13, 2024
BUY
$2.8 - $3.35 $230,112 - $275,313
82,183 Added 4.76%
1,807,912 $5.51 Million
Q3 2023

Nov 13, 2023
BUY
$3.0 - $3.79 $242,073 - $305,818
80,691 Added 4.91%
1,725,729 $5.18 Million
Q2 2023

Aug 11, 2023
BUY
$3.21 - $5.06 $497,466 - $784,168
154,974 Added 10.4%
1,645,038 $6.15 Million
Q1 2023

May 15, 2023
BUY
$3.0 - $4.97 $158,115 - $261,943
52,705 Added 3.67%
1,490,064 $4.99 Million
Q4 2022

Feb 13, 2023
BUY
$4.35 - $6.17 $209,478 - $297,122
48,156 Added 3.47%
1,437,359 $6.91 Million
Q3 2022

Nov 14, 2022
BUY
$5.49 - $8.79 $1.25 Million - $2 Million
227,779 Added 19.61%
1,389,203 $7.9 Million
Q2 2022

Aug 12, 2022
BUY
$5.33 - $8.18 $707,099 - $1.09 Million
132,664 Added 12.9%
1,161,424 $8.25 Million
Q1 2022

May 13, 2022
SELL
$5.5 - $9.19 $286,181 - $478,183
-52,033 Reduced 4.81%
1,028,760 $7.43 Million
Q4 2021

Feb 11, 2022
BUY
$7.67 - $44.59 $369,670 - $2.15 Million
48,197 Added 4.67%
1,080,793 $9.66 Million
Q3 2021

Nov 12, 2021
BUY
$21.33 - $35.06 $7.58 Million - $12.5 Million
355,543 Added 52.51%
1,032,596 $36.2 Million
Q2 2021

Aug 13, 2021
BUY
$19.22 - $59.08 $7.73 Million - $23.8 Million
402,168 Added 146.3%
677,053 $14.5 Million
Q1 2021

May 12, 2021
BUY
$41.42 - $88.44 $290,726 - $620,760
7,019 Added 2.62%
274,885 $17 Million
Q4 2020

Feb 12, 2021
BUY
$26.36 - $41.78 $7.06 Million - $11.2 Million
267,866 New
267,866 $11.2 Million

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $266M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email